• Mon, October 5, 2020
  • Tue, October 6, 2020

Oren Livnat Maintained (VYNE) at Strong Buy with Increased Target to $252 on, Oct 5th, 2020

Oren Livnat of HC Wainwright & Co., Maintained "VYNE Therapeutics Inc." (VYNE) at Strong Buy with Increased Target from $216 to $252 on, Oct 5th, 2020.

Oren, nor any peers, have made any analyst calls on VYNE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍

Similar Stocks and Investing Publications